Article

TearLab, Sjögren’s Foundation partner for dry eye awareness

TearLab is partnering with the Sjögren’s Foundation to promote “Dry Eye Disease Awareness Month” this year. Throughout July, TearLab will raise awareness through professional communications and in-clinic materials delivered directly to customers.

San Diego-TearLab is partnering with the Sjögren’s Foundation to promote “Dry Eye Disease Awareness Month” this year.

Throughout July, TearLab will raise awareness through professional communications and in-clinic materials delivered directly to customers.

The efforts also will extend to social media. TearLab will donate $1 for every “Like” logged in July on the Sjögren’s Syndrome Foundation’s Facebook page, as well as AllAboutDryEye’s Facebook page, a consumer website and social media platform containing information for patients about the prevalence of dry eye disease (DED), and a place for patients to interact and share their stories.

“DED is a common symptom of Sjögren’s, which is why partnering with TearLab to raise awareness of this issue is so important,” said Steve Taylor, chief executive officer of the Sjögren’s Foundation. “We hope that anyone suffering from DED will discuss the possibility of an underlying medical condition, like Sjögren’s, with an eye-care professional."

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.